Bing Zhao
Corporate Officer/Principal en H&J Cro International, Inc. /CN/ .
Cargos activos de Bing Zhao
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| H&J Cro International, Inc. /CN/ | Corporate Officer/Principal | - | - |
| Rundo-Cronova Intl Pharms Research & Development Co., Ltd. | Corporate Officer/Principal | - | - |
Guangzhou Osmunda Medical Device Technical Service Co., Ltd.
 Guangzhou Osmunda Medical Device Technical Service Co., Ltd. Medical SpecialtiesHealth Technology Guangzhou Osmunda Medical Device Technical Service Co., Ltd. engages in providing service in the medical device field. The company was founded in February 2004 and is headquartered in Guangzhou, China. | Corporate Officer/Principal | - | - |
Historial de carrera de Bing Zhao
Antiguos cargos conocidos de Bing Zhao.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | Director Técnico/Científico/I+D | - | - |
| Consejero General | - | - |
Formación de Bing Zhao.
| Xi'an Jiaotong University Health Science Center | Doctorate Degree |
Estadísticas
Internacional
| China | 6 |
Operativa
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| General Counsel | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
| Rundo-Cronova Intl Pharms Research & Development Co., Ltd. | |
Guangzhou Osmunda Medical Device Technical Service Co., Ltd.
Guangzhou Osmunda Medical Device Technical Service Co., Ltd. Medical SpecialtiesHealth Technology Guangzhou Osmunda Medical Device Technical Service Co., Ltd. engages in providing service in the medical device field. The company was founded in February 2004 and is headquartered in Guangzhou, China. | Health Technology |
Xynomic Pharmaceuticals Holdings, Inc.
 Xynomic Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Xynomic Pharmaceuticals Holdings, Inc. is a clinical stage best-in-class oncology therapeutics biopharmaceutical company. It engages in licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. Its current pipeline mainly consists of 3 drug candidates; Xynomic owns global exclusive development, manufacturing and commercialization rights to each of these. Its lead drug candidate abexinostat is in global potentially pivotal clinical trials against renal cell carcinoma and non-Hodgkin's lymphoma. The company was founded by Yinglin Mark Xu on October 7, 2016 and is headquartered in Shanghai, China. | Health Technology |
| H&J Cro International, Inc. /CN/ |
- Bolsa de valores
- Insiders
- Bing Zhao
- Experiencia
